Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers

Ann Surg Oncol. 2024 Apr;31(4):2202-2203. doi: 10.1245/s10434-023-14854-w. Epub 2024 Jan 20.

¹ Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. jonathan.hernandez@nih.gov.
⁴ Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA. mzafereo@mdanderson.org.

No abstract available

Publication types